Lexeo Therapeutics (LXEO) Free Cash Flow (2022 - 2023)
Historic Free Cash Flow for Lexeo Therapeutics (LXEO) over the last 2 years, with Q4 2023 value amounting to -$14.0 million.
- Lexeo Therapeutics' Free Cash Flow rose 1578.28% to -$14.0 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$59.6 million, marking a year-over-year change of. This contributed to the annual value of -$81.6 million for FY2024, which is 3694.12% down from last year.
- Lexeo Therapeutics' Free Cash Flow amounted to -$14.0 million in Q4 2023, which was up 1578.28% from -$14.0 million recorded in Q3 2023.
- Over the past 5 years, Lexeo Therapeutics' Free Cash Flow peaked at -$13.2 million during Q2 2023, and registered a low of -$18.4 million during Q1 2023.